CD74 and glioblastoma: High MIF levels predict significantly reduced overall survival.91 In light of the diversity of MIF-mediated signaling pathways, this association is strengthened when coupled with increased CD74 expression by MDSCs,39 which have been identified as a significant contributor to the immunosuppressive TME in glioblastoma.